NASDAQ:AXSM | Key Financial Ratios | Axsome Therapeutics, Inc.

Complete source-backed ratio history.

Available history
2014-12-31 to 2026-06-30
Data captured

Historical Key Financial Ratios

DateCurrent ratioDebt/equityROAROE
2026-06-301.432.26-25.17%-230.05%
2026-03-311.393.44-26.39%-344.96%
2025-12-311.552.13-26.55%-207.46%
2025-09-301.572.55-34.30%-311.32%
2025-06-301.572.57-38.59%-337.87%
2025-03-312.03-46.64%-523.02%
2024-12-312.113.17-50.52%-503.76%
2024-09-302.44-55.38%-334.73%
2024-06-302.48-56.28%-300.00%
2024-03-313.2-54.31%-205.77%
2023-12-313.63-40.67%-125.27%
2023-09-304.46-33.59%-74.89%
2023-06-304.52-30.16%-66.16%
2023-03-313.02-40.78%-141.95%
2022-12-312.54-56.46%-170.81%
2022-09-304.19-47.17%-101.59%
2022-06-302.44-83.04%-986.45%
2022-03-313.54-158.96%-957.78%
2021-12-313.75-148.55%-834.26%
2021-09-304.66-107.71%-294.00%
2021-06-306.2-79.32%-159.07%
2021-03-317.61-59.72%-103.51%
2020-12-317.85-55.28%-90.43%
2020-09-309.99-48.39%-72.85%
2020-06-308.30.13-49.61%-61.43%
2020-03-317.570.13-45.60%-57.76%
2019-12-3190.11-30.99%-38.24%
2019-09-302.392.9-119.57%-778.81%
2019-06-304.180.81-77.19%-174.12%
2019-03-315.681.11-83.83%-211.82%
2018-12-311.417.37-201.35%-3301.50%
2018-09-301.4610.4-178.59%-3877.30%
2018-06-302.261.21-124.05%-384.52%
2018-03-312.950.73-92.18%-204.62%
2017-12-312.90.59-81.40%-173.14%
2017-09-303.860.6-88.42%-171.28%
2017-06-304.730.44-75.82%-130.10%
2017-03-315.530.34-63.20%-100.17%
2016-12-315.30.45-71.19%-126.10%
2016-09-305.16-66.55%-82.45%
2016-06-307.82-51.54%-59.07%
2016-03-3111.51-35.30%-38.65%
2015-12-3118.63-24.88%-26.29%

Annual Key Financial Ratios

DateCurrent ratioDebt/equityROAROE
2025-12-311.552.13-26.55%-207.46%
2024-12-312.113.17-50.52%-503.76%
2023-12-313.63-40.67%-125.27%
2022-12-312.54-56.45%-170.81%
2021-12-313.75-148.55%-834.26%
2020-12-317.85-55.28%-90.43%
2019-12-3190.11-30.99%-38.24%
2018-12-311.417.37-201.35%-3301.50%
2017-12-312.90.59-81.40%-173.14%
2016-12-315.30.45-71.19%-126.10%
2015-12-3118.63-24.88%-26.29%
2014-12-31187.37%